Targeting BCL6 in diffuse large B-cell lymphoma: what does this mean for the future treatment?
about
Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewThe curious origins of angioimmunoblastic T-cell lymphomamiR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphomaRationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma.
P2860
Targeting BCL6 in diffuse large B-cell lymphoma: what does this mean for the future treatment?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Targeting BCL6 in diffuse larg ...... mean for the future treatment?
@en
Targeting BCL6 in diffuse larg ...... mean for the future treatment?
@nl
type
label
Targeting BCL6 in diffuse larg ...... mean for the future treatment?
@en
Targeting BCL6 in diffuse larg ...... mean for the future treatment?
@nl
prefLabel
Targeting BCL6 in diffuse larg ...... mean for the future treatment?
@en
Targeting BCL6 in diffuse larg ...... mean for the future treatment?
@nl
P2860
P1476
Targeting BCL6 in diffuse larg ...... mean for the future treatment?
@en
P2093
Ari Melnick
P2860
P304
P356
10.1586/17474086.2013.826928
P577
2013-08-01T00:00:00Z